U.S. inflation accelerated last month, unwelcome news that make lower interest rates less likely any time soon.

Through a multi-year deal with the UFC, the Monster Beverage (NASDAQ: MNST) logo will continue to enjoy prominent placement ...

Argus analyst Kevin Heal raised the firm’s price target on Nasdaq (NDAQ) to $88 from $82 and keeps a Buy rating on the shares. The company’s ...

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference, with a webcast available at Nasdaq’s Investor Relations website: ...

Stocks swooned at the open Monday on steep tariffs set to start later this but reversed losses on news of possible deals with ...

Feb. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and ... planning and execution in companies such as Thermo Fisher Scientific – Viral Vector Services, RGI ...

Presentation Operator Greetings, and welcome to the Fourth Quarter 2024 Teradyne Inc. Earnings Conference Call. At this time, ...

CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...

Merchandising! Merchandising! That’s where the real money from the movie is made, if you listened to wise old Yogurt from the comedy classic Spaceballs. And the Schwartz was assuredly with ...

NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:NB) today announced the pricing of an underwritten offering of 2,577,320 common shares, 2,577,320 Series A warrants to purchase up to ...

Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a ...

While electric vehicle giant Tesla (TSLA) has had things a bit rough lately, particularly given the market demand for electric vehicles of late, there are some positive signs ahead. Some reports ...